MSN Pharmaceuticals, Inc. v. Novartis Pharmaceuticals Corp.
Certiorari Denied
Petition for certiorari denied on December 15, 2025.
Issue
Whether, in a patent-infringement suit, a court may consider after-arising technology to hold that the patent is invalid under 35 U.S.C. § 112(a) of the Patent Act.
Jun 6, 2025Application (24A1215) to extend the time to file a petition for a writ of certiorari from June 23, 2025 to August 22, 2025, submitted to The Chief Justice.
Jun 11, 2025Application (24A1215) granted by The Chief Justice extending the time to file until August 22, 2025.
Aug 22, 2025Petition for a writ of certiorari filed. (Response due September 25, 2025)Sep 2, 2025Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.Sep 3, 2025DISTRIBUTED for Conference of 9/29/2025.
Sep 3, 2025Brief amicus curiae of Association for Accessible Medicines filed. (Distributed)Sep 4, 2025Letter from counsel of MSN Pharmaceuticals, Inc., et al. received.Sep 8, 2025Response Requested. (Due October 8, 2025)
Sep 17, 2025Motion to extend the time to file a response from October 8, 2025 to November 7, 2025, submitted to The Clerk.Sep 18, 2025Motion to extend the time to file a response is granted and the time is extended to and including November 7, 2025.
Oct 1, 2025Brief amicus curiae of Unified Patents, LLC filed.Oct 8, 2025Brief amicus curiae of Public Interest Patent Law Institute filed.Oct 8, 2025Brief amici curiae of Biophore Pharma, Inc., et al. filed.Oct 8, 2025Brief amicus curiae of Sigmapharm Laboratories, LLC filed.Oct 8, 2025Brief amici curiae of Professor Jonathan Masur, et al. filed.Oct 8, 2025Brief amici curiae of Intellectual Property Law Professors filed.Nov 7, 2025Brief of respondent Novartis Pharmaceuticals Corporation in opposition filed.Nov 25, 2025DISTRIBUTED for Conference of 12/12/2025.
Nov 25, 2025Reply of petitioners MSN Pharmaceuticals, Inc., et al. filed. (Distributed)Dec 15, 2025Petition DENIED.
Recommended Citation: MSN Pharmaceuticals, Inc. v. Novartis Pharmaceuticals Corp., SCOTUSblog, https://www.scotusblog.com/cases/msn-pharmaceuticals-inc-v-novartis-pharmaceuticals-corp/